A Japanese pharmaceutical manufacturer focused on prescription medicines for central nervous system disorders, immunology, and metabolic diseases. The company has developed treatments for conditions such as ALS and diabetes and historically operated as a core healthcare unit within Mitsubishi Chemic...
2 members of Congress have disclosed 9 trades in Mitsubishi Tanabe Pharma (MTZPY), a Healthcare company. The buy/sell breakdown shows 7 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-20 | David P. Roe | buy | $1K – $15K |
| 2019-05-14 | David P. Roe | buy | $1K – $15K |
| 2019-04-11 | David P. Roe | buy | $1K – $15K |
| 2019-02-22 | David P. Roe | sell | $1K – $15K |
| 2018-11-21 | David P. Roe | buy | $15K – $50K |
| 2018-11-19 | Greg Gianforte | sell | $15K – $50K |
| 2018-10-18 | David P. Roe | buy | $1K – $15K |
| 2018-09-18 | David P. Roe | buy | $1K – $15K |
| 2018-05-23 | David P. Roe | buy | $15K – $50K |